Statera Biopharma Pink Sheet Forecast - Simple Regression

STAB Stock  USD 0.0003  0.0002  200.00%   
The Simple Regression forecasted value of Statera Biopharma on the next trading day is expected to be 0.0002 with a mean absolute deviation of 0.000052 and the sum of the absolute errors of 0. Statera Pink Sheet Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Statera Biopharma stock prices and determine the direction of Statera Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Statera Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Statera Biopharma's share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Statera Biopharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Statera Biopharma, which may create opportunities for some arbitrage if properly timed.
Using Statera Biopharma hype-based prediction, you can estimate the value of Statera Biopharma from the perspective of Statera Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Statera Biopharma on the next trading day is expected to be 0.0002 with a mean absolute deviation of 0.000052 and the sum of the absolute errors of 0.

Statera Biopharma after-hype prediction price

    
  USD 2.7E-4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of Statera Biopharma to cross-verify your projections.

Statera Biopharma Additional Predictive Modules

Most predictive techniques to examine Statera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Statera using various technical indicators. When you analyze Statera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Simple Regression model is a single variable regression model that attempts to put a straight line through Statera Biopharma price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Statera Biopharma Simple Regression Price Forecast For the 3rd of January

Given 90 days horizon, the Simple Regression forecasted value of Statera Biopharma on the next trading day is expected to be 0.0002 with a mean absolute deviation of 0.000052, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Statera Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Statera Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Statera Biopharma Pink Sheet Forecast Pattern

Backtest Statera BiopharmaStatera Biopharma Price PredictionBuy or Sell Advice 

Statera Biopharma Forecasted Value

In the context of forecasting Statera Biopharma's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Statera Biopharma's downside and upside margins for the forecasting period are 0.000003 and 49.37, respectively. We have considered Statera Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0003
0.000003
Downside
0.0002
Expected Value
49.37
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Statera Biopharma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Statera Biopharma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria98.6924
BiasArithmetic mean of the errors None
MADMean absolute deviation1.0E-4
MAPEMean absolute percentage error0.3678
SAESum of the absolute errors0.0031
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Statera Biopharma historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Statera Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Statera Biopharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.000348.99
Details
Intrinsic
Valuation
LowRealHigh
0.000.000248.99
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Statera Biopharma. Your research has to be compared to or analyzed against Statera Biopharma's peers to derive any actionable benefits. When done correctly, Statera Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Statera Biopharma.

Other Forecasting Options for Statera Biopharma

For every potential investor in Statera, whether a beginner or expert, Statera Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Statera Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Statera. Basic forecasting techniques help filter out the noise by identifying Statera Biopharma's price trends.

Statera Biopharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Statera Biopharma pink sheet to make a market-neutral strategy. Peer analysis of Statera Biopharma could also be used in its relative valuation, which is a method of valuing Statera Biopharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Statera Biopharma Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Statera Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Statera Biopharma's current price.

Statera Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Statera Biopharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Statera Biopharma shares will generate the highest return on investment. By undertsting and applying Statera Biopharma pink sheet market strength indicators, traders can identify Statera Biopharma entry and exit signals to maximize returns.

Statera Biopharma Risk Indicators

The analysis of Statera Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Statera Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting statera pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Statera Pink Sheet

Statera Biopharma financial ratios help investors to determine whether Statera Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Statera with respect to the benefits of owning Statera Biopharma security.